Yi Hong Liao
Fortune : 11 M $ au 30/09/2026
Fortune : 11 M $ au 30/09/2026
Yi Hong Liao is currently a Non-Executive Director at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. since 2025 and a Member of the Supervisory Board at Sichuan Kelun Pharmacy Institute Co., Ltd. since 2020.
Formerly, Ms. Liao worked as an Audit Manager at Kpmg Consulting China Co. Ltd. from 2006 to 2014.
Education includes a graduate degree from Tsinghua University conferred in 2021 and an undergraduate degree from Guangdong University of Foreign Studies conferred in 2020.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 170 000 ( 0,1 % ) | 11 M $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 01/06/2025 |
Sichuan Kelun Pharmacy Institute Co., Ltd.
Sichuan Kelun Pharmacy Institute Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Directeur/Membre du Conseil | 05/11/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Kpmg Consulting China Co. Ltd. | Comptroller/Controller/Auditor | 01/11/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangdong University of Foreign Studies
Guangdong University of Foreign Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kpmg Consulting China Co. Ltd. | |
Sichuan Kelun Pharmacy Institute Co., Ltd.
Sichuan Kelun Pharmacy Institute Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes drugs for treatment | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national